Male hormonal contraception: a double-blind, placebo-controlled study

The Journal of Clinical Endocrinology and Metabolism
Ellen MommersMichael Zitzmann

Abstract

This study was performed to assess spermatogenesis suppression and safety of a new combination of an etonogestrel (ENG) implant combined with testosterone undecanoate (TU) injections for male contraception. This is the first large placebo-controlled study for male hormonal contraception. In this double-blind, multicenter study, we randomly assigned 354 healthy men to receive either a low- or high-release ENG implant sc combined with im TU injections (750 mg every 10 or 12 wk or 1000 mg every 12 wk) or placebo implant and injections. Treatment duration was 42 or 44 wk and posttreatment follow-up at least 24 wk. Overall, spermatogenesis was suppressed to 1 million/ml or less at wk 16 in 89% of men, with approximately 94% in two high-release ENG groups. Suppression was maintained up to the end of the treatment period in 91% of men. For all men who completed the treatment period, 3% never achieved 1 million/ml or less. Median recovery time to a sperm concentration above 20 million/ml was 15 wk (mean 17 wk, 95% confidence interval 16-18 wk). Treatment was well tolerated. As compared with the placebo group, more men in the active treatment groups reported adverse events such as weight gain, mood changes, acne, sweating, or libido cha...Continue Reading

References

Apr 1, 1996·Fertility and Sterility·UNKNOWN World Health Organization Task Force on Methods for the Regulation of Male Fertility
Feb 12, 2002·The Journal of Clinical Endocrinology and Metabolism·Axel KamischkeEberhard Nieschlag
Aug 6, 2002·The Journal of Clinical Endocrinology and Metabolism·R A AndersonD T Baird
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·Yi-Qun GuGui-Yuan Zhang
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Leo TurnerDavid J Handelsman
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Robert I McLachlanCristina Meriggiola
Dec 21, 2004·Human Reproduction·Klaas HeinemannLothar Heinemann
Sep 1, 2005·International Journal of Andrology·Joseph JonckheereTrevor G Cooper
Apr 7, 2006·Human Reproduction Update·Kati L Matthiesson, Robert I McLachlan
Apr 7, 2006·Journal of Andrology·T G CooperC Wang
May 3, 2006·Lancet·Peter Y LiuUNKNOWN Hormonal Male Contraception Summit Group
Jul 21, 2006·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Melanie Wenk, Eberhard Nieschlag

❮ Previous
Next ❯

Citations

Jan 9, 2010·Der Urologe. Ausg. A·M Zitzmann
May 7, 2011·Reviews in Endocrine & Metabolic Disorders·Niloufar IlaniChristina Wang
Sep 22, 2012·Contraception·Regine Sitruk-WareDaniel R Mishell
Sep 25, 2012·Asian Journal of Andrology·Eberhard Nieschlag, Alexander Lerchl
Sep 3, 2010·Current Opinion in Urology·Christina Wang, Ronald S Swerdloff
Apr 16, 2009·The Journal of Clinical Endocrinology and Metabolism·Vahid MahabadiChristina Wang
Jul 14, 2012·The Journal of Clinical Endocrinology and Metabolism·Niloufar IlaniChristina Wang
Feb 2, 2010·Asian Journal of Andrology·Gideon SartoriusDavid J Handelsman
Dec 12, 2012·Indian Journal of Endocrinology and Metabolism·Vivek Mathew, Ganapathi Bantwal
Nov 3, 2012·The Virtual Mentor : VM·Mara Y Roth
Apr 14, 2012·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Ahmed Mahmoud, Guy T'Sjoen
Jul 24, 2012·Fertility and Sterility·Claire E BeyerTiki Osianlis
Jun 10, 2011·International Journal of Andrology·E NieschlagM Zitzmann
Feb 27, 2016·The Lancet. Diabetes & Endocrinology·Katarzyna PiotrowskaPeter Y Liu
Jul 6, 2014·Journal of Health Psychology·Lorelle DismoreKatherine Swainston
Jun 26, 2008·The Journal of Family Planning and Reproductive Health Care·Malcolm Potts, Martha Campbell
Sep 10, 2010·Clinical Pharmacology and Therapeutics·M Y Roth, J K Amory
Aug 7, 2009·Nature Reviews. Urology·Robert E Brannigan
Mar 16, 2012·The Cochrane Database of Systematic Reviews·David A GrimesKenneth F Schulz
Sep 25, 2012·Clinical Endocrinology·Robert I McLachlan
Oct 11, 2015·Andrology·M Y RothW J Bremner
Sep 21, 2019·BMJ Sexual & Reproductive Health·John Joseph Reynolds-Wright, Richard Anderson
May 27, 2009·Current Opinion in Obstetrics & Gynecology·Rajesh K Naz, Shon Rowan
Oct 17, 2019·Clinical and Translational Science·John K Amory
Jul 12, 2008·The Journal of Clinical Endocrinology and Metabolism·Peter Y Liu, Robert I McLachlan
Mar 19, 2009·The Journal of Clinical Endocrinology and Metabolism·Yiqun GuKangshou Yao
Oct 28, 2016·The Journal of Clinical Endocrinology and Metabolism·Hermann M BehreDoug S Colvard
Mar 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Robert I McLachlan
Mar 8, 2016·Current Obstetrics and Gynecology Reports·Christina WangRonald S Swerdloff
Mar 23, 2019·Therapeutic Advances in Endocrinology and Metabolism·Giulia Gava, Maria Cristina Meriggiola
Jan 23, 2021·The Journal of Clinical Endocrinology and Metabolism·Jill E LongDiana L Blithe
Oct 12, 2010·Contraception·Peter Y LiuChristina Wang
May 22, 2009·Current Opinion in Obstetrics & Gynecology
Oct 14, 2010·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.